Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats

Although the negative effects coming along with opiate withdrawal are in part modulated by L-type calcium channels (LTCCs), the distinctive physiological properties and functions of LTCCs subtypes suggest differential roles of subtypes during withdrawal. The present study aimed to examine the contri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Progress in neuro-psychopharmacology & biological psychiatry 2023-12, Vol.127, p.110818-110818, Article 110818
Hauptverfasser: Duan, Ying, Jin, Lingtong, Du, Wenjie, Meng, Yiming, Liang, Jing, Zhang, Jianjun, Sui, Nan, Shen, Fang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 110818
container_issue
container_start_page 110818
container_title Progress in neuro-psychopharmacology & biological psychiatry
container_volume 127
creator Duan, Ying
Jin, Lingtong
Du, Wenjie
Meng, Yiming
Liang, Jing
Zhang, Jianjun
Sui, Nan
Shen, Fang
description Although the negative effects coming along with opiate withdrawal are in part modulated by L-type calcium channels (LTCCs), the distinctive physiological properties and functions of LTCCs subtypes suggest differential roles of subtypes during withdrawal. The present study aimed to examine the contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion (CPA) paradigm. Firstly, we injected the non-specific LTCCs antagonist verapamil into the DH of morphine-dependent rats before conditioning an environment with naloxone-precipitated withdrawal. Our results showed that verapamil blocked the acquisition of CPA. Then, to explore the molecular mechanisms of LTCCs subtypes during withdrawal, we measured the protein expression of Cav1.2 and Cav1.3 in morphine-dependent rats under different conditions. In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3. To further determine the causal roles of LTCCs subtypes in the withdrawal process, we used Cav1.2 siRNA or Cav1.3 shRNA to knock down the expression of subtypes and detected the effects on CPA and somatic withdrawal signs in morphine-dependent rats. Cav1.2 siRNA, but not Cav1.3 shRNA, inhibited the acquirement of CPA and relieved somatic withdrawal symptoms. Together, our findings reveal that Cav1.2, but not Cav1.3 plays an important role in mediating morphine withdrawal, suggesting this subtype may serve as a potential therapeutic target for the treatment of negative effects in opiate dependence. •The contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion paradigm.•In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3.•Cav1.2, but not Cav1.3 play an important role in mediating conditioned aversion induced by naloxone-precipitated morphine withdrawal.
doi_str_mv 10.1016/j.pnpbp.2023.110818
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2829426413</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584623001045</els_id><sourcerecordid>2829426413</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-af138864a1d4cd73e492e816db83fc2d36ab0161f6b87ca35d9c13eee2296dea3</originalsourceid><addsrcrecordid>eNp9kcuO1DAQRS0EYpqBL0BCXrJJ40c67SxYoOExI7XEBtaWY1fUbiW2cTk9mr_gk3GmB5asqqQ6t0p1LyFvOdtyxrsPp20KaUhbwYTccs4UV8_Ihqu9alrBu-dkw0Ttd6rtrsgrxBNjjEsmX5IruZet6lq-Ib8_eyw-2OLPQHOcAGkc6aEpDwmoNZP1y0zt0YQAE1JchnWA9N6Xow-0HIG6mNFM9OhTitbMaUFaJ2PMsyk-hnXdHHOqODzKXDb3Zmp8cIsFR80ZMq5cFWVT8DV5MZoJ4c1TvSY_v375cXPbHL5_u7v5dGis3PWlMSOXqr5guGut20toewGKd25QcrTCyc4M1SQ-doPaWyN3rrdcAoAQfefAyGvy_rI35fhrASx69mhhmkyAuKAWSvStqB7JisoLanNEzDDqlP1s8oPmTK9R6JN-jEKvUehLFFX17unAMszg_mn-el-BjxegOgtnD1mj9RCqKT6DLdpF_98DfwC5J59l</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2829426413</pqid></control><display><type>article</type><title>Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Duan, Ying ; Jin, Lingtong ; Du, Wenjie ; Meng, Yiming ; Liang, Jing ; Zhang, Jianjun ; Sui, Nan ; Shen, Fang</creator><creatorcontrib>Duan, Ying ; Jin, Lingtong ; Du, Wenjie ; Meng, Yiming ; Liang, Jing ; Zhang, Jianjun ; Sui, Nan ; Shen, Fang</creatorcontrib><description>Although the negative effects coming along with opiate withdrawal are in part modulated by L-type calcium channels (LTCCs), the distinctive physiological properties and functions of LTCCs subtypes suggest differential roles of subtypes during withdrawal. The present study aimed to examine the contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion (CPA) paradigm. Firstly, we injected the non-specific LTCCs antagonist verapamil into the DH of morphine-dependent rats before conditioning an environment with naloxone-precipitated withdrawal. Our results showed that verapamil blocked the acquisition of CPA. Then, to explore the molecular mechanisms of LTCCs subtypes during withdrawal, we measured the protein expression of Cav1.2 and Cav1.3 in morphine-dependent rats under different conditions. In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3. To further determine the causal roles of LTCCs subtypes in the withdrawal process, we used Cav1.2 siRNA or Cav1.3 shRNA to knock down the expression of subtypes and detected the effects on CPA and somatic withdrawal signs in morphine-dependent rats. Cav1.2 siRNA, but not Cav1.3 shRNA, inhibited the acquirement of CPA and relieved somatic withdrawal symptoms. Together, our findings reveal that Cav1.2, but not Cav1.3 plays an important role in mediating morphine withdrawal, suggesting this subtype may serve as a potential therapeutic target for the treatment of negative effects in opiate dependence. •The contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion paradigm.•In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3.•Cav1.2, but not Cav1.3 play an important role in mediating conditioned aversion induced by naloxone-precipitated morphine withdrawal.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2023.110818</identifier><identifier>PMID: 37348641</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>conditioned place aversion (CPA) ; dorsal hippocampus (DH) ; LTCCs subtypes ; Opiate withdrawal ; RNA interference</subject><ispartof>Progress in neuro-psychopharmacology &amp; biological psychiatry, 2023-12, Vol.127, p.110818-110818, Article 110818</ispartof><rights>2023</rights><rights>Copyright © 2023. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-af138864a1d4cd73e492e816db83fc2d36ab0161f6b87ca35d9c13eee2296dea3</citedby><cites>FETCH-LOGICAL-c359t-af138864a1d4cd73e492e816db83fc2d36ab0161f6b87ca35d9c13eee2296dea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pnpbp.2023.110818$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37348641$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duan, Ying</creatorcontrib><creatorcontrib>Jin, Lingtong</creatorcontrib><creatorcontrib>Du, Wenjie</creatorcontrib><creatorcontrib>Meng, Yiming</creatorcontrib><creatorcontrib>Liang, Jing</creatorcontrib><creatorcontrib>Zhang, Jianjun</creatorcontrib><creatorcontrib>Sui, Nan</creatorcontrib><creatorcontrib>Shen, Fang</creatorcontrib><title>Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats</title><title>Progress in neuro-psychopharmacology &amp; biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Although the negative effects coming along with opiate withdrawal are in part modulated by L-type calcium channels (LTCCs), the distinctive physiological properties and functions of LTCCs subtypes suggest differential roles of subtypes during withdrawal. The present study aimed to examine the contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion (CPA) paradigm. Firstly, we injected the non-specific LTCCs antagonist verapamil into the DH of morphine-dependent rats before conditioning an environment with naloxone-precipitated withdrawal. Our results showed that verapamil blocked the acquisition of CPA. Then, to explore the molecular mechanisms of LTCCs subtypes during withdrawal, we measured the protein expression of Cav1.2 and Cav1.3 in morphine-dependent rats under different conditions. In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3. To further determine the causal roles of LTCCs subtypes in the withdrawal process, we used Cav1.2 siRNA or Cav1.3 shRNA to knock down the expression of subtypes and detected the effects on CPA and somatic withdrawal signs in morphine-dependent rats. Cav1.2 siRNA, but not Cav1.3 shRNA, inhibited the acquirement of CPA and relieved somatic withdrawal symptoms. Together, our findings reveal that Cav1.2, but not Cav1.3 plays an important role in mediating morphine withdrawal, suggesting this subtype may serve as a potential therapeutic target for the treatment of negative effects in opiate dependence. •The contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion paradigm.•In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3.•Cav1.2, but not Cav1.3 play an important role in mediating conditioned aversion induced by naloxone-precipitated morphine withdrawal.</description><subject>conditioned place aversion (CPA)</subject><subject>dorsal hippocampus (DH)</subject><subject>LTCCs subtypes</subject><subject>Opiate withdrawal</subject><subject>RNA interference</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kcuO1DAQRS0EYpqBL0BCXrJJ40c67SxYoOExI7XEBtaWY1fUbiW2cTk9mr_gk3GmB5asqqQ6t0p1LyFvOdtyxrsPp20KaUhbwYTccs4UV8_Ihqu9alrBu-dkw0Ttd6rtrsgrxBNjjEsmX5IruZet6lq-Ib8_eyw-2OLPQHOcAGkc6aEpDwmoNZP1y0zt0YQAE1JchnWA9N6Xow-0HIG6mNFM9OhTitbMaUFaJ2PMsyk-hnXdHHOqODzKXDb3Zmp8cIsFR80ZMq5cFWVT8DV5MZoJ4c1TvSY_v375cXPbHL5_u7v5dGis3PWlMSOXqr5guGut20toewGKd25QcrTCyc4M1SQ-doPaWyN3rrdcAoAQfefAyGvy_rI35fhrASx69mhhmkyAuKAWSvStqB7JisoLanNEzDDqlP1s8oPmTK9R6JN-jEKvUehLFFX17unAMszg_mn-el-BjxegOgtnD1mj9RCqKT6DLdpF_98DfwC5J59l</recordid><startdate>20231220</startdate><enddate>20231220</enddate><creator>Duan, Ying</creator><creator>Jin, Lingtong</creator><creator>Du, Wenjie</creator><creator>Meng, Yiming</creator><creator>Liang, Jing</creator><creator>Zhang, Jianjun</creator><creator>Sui, Nan</creator><creator>Shen, Fang</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231220</creationdate><title>Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats</title><author>Duan, Ying ; Jin, Lingtong ; Du, Wenjie ; Meng, Yiming ; Liang, Jing ; Zhang, Jianjun ; Sui, Nan ; Shen, Fang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-af138864a1d4cd73e492e816db83fc2d36ab0161f6b87ca35d9c13eee2296dea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>conditioned place aversion (CPA)</topic><topic>dorsal hippocampus (DH)</topic><topic>LTCCs subtypes</topic><topic>Opiate withdrawal</topic><topic>RNA interference</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duan, Ying</creatorcontrib><creatorcontrib>Jin, Lingtong</creatorcontrib><creatorcontrib>Du, Wenjie</creatorcontrib><creatorcontrib>Meng, Yiming</creatorcontrib><creatorcontrib>Liang, Jing</creatorcontrib><creatorcontrib>Zhang, Jianjun</creatorcontrib><creatorcontrib>Sui, Nan</creatorcontrib><creatorcontrib>Shen, Fang</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duan, Ying</au><au>Jin, Lingtong</au><au>Du, Wenjie</au><au>Meng, Yiming</au><au>Liang, Jing</au><au>Zhang, Jianjun</au><au>Sui, Nan</au><au>Shen, Fang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats</atitle><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2023-12-20</date><risdate>2023</risdate><volume>127</volume><spage>110818</spage><epage>110818</epage><pages>110818-110818</pages><artnum>110818</artnum><issn>0278-5846</issn><eissn>1878-4216</eissn><abstract>Although the negative effects coming along with opiate withdrawal are in part modulated by L-type calcium channels (LTCCs), the distinctive physiological properties and functions of LTCCs subtypes suggest differential roles of subtypes during withdrawal. The present study aimed to examine the contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion (CPA) paradigm. Firstly, we injected the non-specific LTCCs antagonist verapamil into the DH of morphine-dependent rats before conditioning an environment with naloxone-precipitated withdrawal. Our results showed that verapamil blocked the acquisition of CPA. Then, to explore the molecular mechanisms of LTCCs subtypes during withdrawal, we measured the protein expression of Cav1.2 and Cav1.3 in morphine-dependent rats under different conditions. In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3. To further determine the causal roles of LTCCs subtypes in the withdrawal process, we used Cav1.2 siRNA or Cav1.3 shRNA to knock down the expression of subtypes and detected the effects on CPA and somatic withdrawal signs in morphine-dependent rats. Cav1.2 siRNA, but not Cav1.3 shRNA, inhibited the acquirement of CPA and relieved somatic withdrawal symptoms. Together, our findings reveal that Cav1.2, but not Cav1.3 plays an important role in mediating morphine withdrawal, suggesting this subtype may serve as a potential therapeutic target for the treatment of negative effects in opiate dependence. •The contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion paradigm.•In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3.•Cav1.2, but not Cav1.3 play an important role in mediating conditioned aversion induced by naloxone-precipitated morphine withdrawal.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>37348641</pmid><doi>10.1016/j.pnpbp.2023.110818</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-5846
ispartof Progress in neuro-psychopharmacology & biological psychiatry, 2023-12, Vol.127, p.110818-110818, Article 110818
issn 0278-5846
1878-4216
language eng
recordid cdi_proquest_miscellaneous_2829426413
source Elsevier ScienceDirect Journals Complete
subjects conditioned place aversion (CPA)
dorsal hippocampus (DH)
LTCCs subtypes
Opiate withdrawal
RNA interference
title Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T14%3A59%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distinctive%20roles%20of%20L-type%20calcium%20channels%20subtypes%20within%20the%20dorsal%20hippocampus%20in%20formation%20of%20morphine%20withdrawal-induced%20aversion%20in%20rats&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Duan,%20Ying&rft.date=2023-12-20&rft.volume=127&rft.spage=110818&rft.epage=110818&rft.pages=110818-110818&rft.artnum=110818&rft.issn=0278-5846&rft.eissn=1878-4216&rft_id=info:doi/10.1016/j.pnpbp.2023.110818&rft_dat=%3Cproquest_cross%3E2829426413%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2829426413&rft_id=info:pmid/37348641&rft_els_id=S0278584623001045&rfr_iscdi=true